Table 1 Demographic and clinical characteristics of patients with systemic lupus erythematosus (SLE) and healthy controls
SLE patients (n = 50) | Healthy controls (n = 50) | |
|---|---|---|
Demographic characteristics | ||
Age at study, years, mean ± SD | 40.2 ± 10.5 | 40.3 ± 10.6 |
Sex, female:male | 48:2 | 48:2 |
Clinical characteristics | ||
Arthritis, n (%) | 49 (98%) | |
Skin involvement, n (%) | 41 (82%) | |
Glomerulonephritis (class), n (%) | 28 (56%) | |
Class IV: 21 | ||
Class V: 3 | ||
Class III: 2 | ||
Class II: 2 | ||
Haematologic involvement, n (%) | 21 (42%) | |
Hemolytic anemia 22% | ||
Thrombocytopenia 34% | ||
Serositis, n (%) | 14 (28%) | |
Neurological involvement, n (%) | 8 (16%) | |
SLEDAI score, mean ± SD (range) | 5.92 ± 5.89 (0, 26) | |
SLICC score mean ± SD (range) | 1.52 ± 1.59 (0, 7) | |
Oral anticoagulation, n | 5 | 0 |